113 related articles for article (PubMed ID: 31343933)
1. Impact of Initiating Screening Programs on Referral and Management of Cervical Cancer in Tanzania.
Sedani A; Soliman AS; Msami K; Msemo D; Mwaiselage J; Schmid K; Kahesa C
J Glob Oncol; 2019 Jul; 5():JGO1800052. PubMed ID: 31343933
[TBL] [Abstract][Full Text] [Related]
2. Most women diagnosed with cervical cancer by a visual screening program in Tanzania completed treatment: evidence from a retrospective cohort study.
Gard AC; Soliman AS; Ngoma T; Mwaiselage J; Kahesa C; Chamberlain RM; Harlow SD
BMC Public Health; 2014 Sep; 14():910. PubMed ID: 25187329
[TBL] [Abstract][Full Text] [Related]
3. Needs for Professional Education to Optimize Cervical Cancer Screenings in Low-Income Countries: a Case Study from Tanzania.
Lavelle AE; Su D; Kahesa C; Soliman AS
J Cancer Educ; 2019 Feb; 34(1):124-129. PubMed ID: 28895070
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the need of educational programs for cervical screening in rural Tanzania.
Peters LM; Soliman AS; Bukori P; Mkuchu J; Ngoma T
J Cancer Educ; 2010 Jun; 25(2):153-9. PubMed ID: 20204578
[TBL] [Abstract][Full Text] [Related]
5. Downstaging of cervical cancer in Tanzania over a 16-year period.
Mattick LJ; Ochs-Balcom HM; Mwaiselage J; Kahesa C; Gard AC; Shalan F; Soliman AS
Cancer Causes Control; 2021 Apr; 32(4):401-407. PubMed ID: 33559768
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania.
Cherlin DS; Mwaiselage J; Msami K; Heisler Z; Young H; Cui Q; Soliman AS
Biomed Res Int; 2022; 2022():9795534. PubMed ID: 35425839
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries.
Nelson S; Kim J; Wilson FA; Soliman AS; Ngoma T; Kahesa C; Mwaiselage J
Value Health Reg Issues; 2016 Sep; 10():1-6. PubMed ID: 27881270
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.
Lovgren K; Soliman AS; Ngoma T; Kahesa C; Meza J
Int J STD AIDS; 2016 Oct; 27(12):1049-1056. PubMed ID: 26464500
[TBL] [Abstract][Full Text] [Related]
9. The impact of in-house pathology services on downstaging cervical cancer in Tanzania over an 18-year period.
Fuss CG; Msami K; Kahesa C; Mwaiselage J; Gordon A; Sohler N; Mattick LJ; Soliman AS
Cancer Causes Control; 2024 Jan; 35(1):93-101. PubMed ID: 37574489
[TBL] [Abstract][Full Text] [Related]
10. Quantifying the under-estimation of cervical Cancer in remote regions of Tanzania.
Gesink MP; Chamberlain RM; Mwaiselage J; Kahesa C; Jackson K; Mueller W; Meza JL; Soliman AS
BMC Cancer; 2020 Sep; 20(1):939. PubMed ID: 32998702
[TBL] [Abstract][Full Text] [Related]
11. Return on Investment of a Breast Cancer Screening Program in Tanzania: Opportunity for Patient and Public Education.
Heisler Z; Eastwood B; Mwaiselage J; Kahesa C; Msami K; Soliman AS
J Cancer Educ; 2022 Jun; 37(3):701-708. PubMed ID: 32980979
[TBL] [Abstract][Full Text] [Related]
12. Quality of life among cervical cancer patients following completion of chemoradiotherapy at Ocean Road Cancer Institute (ORCI) in Tanzania.
Mvunta DH; August F; Dharsee N; Mvunta MH; Wangwe P; Ngarina M; Simba BM; Kidanto H
BMC Womens Health; 2022 Oct; 22(1):426. PubMed ID: 36303143
[TBL] [Abstract][Full Text] [Related]
13. Situational analysis for diagnosis and treatment of cervical cancer in mainland Tanzania.
Ngwalle EW; Mgaya HN; Mpanju-Shumbusho W; Chirenje ZM; Kirumbi L; Lebelle T; Kaggwa S
East Afr Med J; 2001 Feb; 78(2):60-4. PubMed ID: 11682947
[TBL] [Abstract][Full Text] [Related]
14. Competing needs: a qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania.
Linde DS; Rasch V; Mwaiselage JD; Gammeltoft TM
BMJ Open; 2019 Feb; 9(2):e024011. PubMed ID: 30819704
[TBL] [Abstract][Full Text] [Related]
15. Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer Patients.
Spees LP; Brewster WR; Varia MA; Weinberger M; Baggett C; Zhou X; Petermann VM; Wheeler SB
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):882-889. PubMed ID: 30733307
[TBL] [Abstract][Full Text] [Related]
16. Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study.
Olwanda E; Shen J; Kahn JG; Bryant-Comstock K; Huchko MJ
Glob Health Action; 2018; 11(1):1451455. PubMed ID: 29589991
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania.
Cunningham MS; Skrastins E; Fitzpatrick R; Jindal P; Oneko O; Yeates K; Booth CM; Carpenter J; Aronson KJ
BMJ Open; 2015 Mar; 5(3):e005828. PubMed ID: 25757944
[TBL] [Abstract][Full Text] [Related]
18. Factors related to completion of referral among women with suspected cervical cancer and dysplasia in Tanzania.
Yim ET; Rogers TB; Msami K; Calixte R; Kahesa C; Mwaiselage JD; Dorn J; Soliman AS
Int J Gynaecol Obstet; 2021 Jan; 152(1):88-95. PubMed ID: 33025590
[TBL] [Abstract][Full Text] [Related]
19. Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders' Perceptions of Structural Influences on Scale-Up.
McCree R; Giattas MR; Sahasrabuddhe VV; Jolly PE; Martin MY; Usdan SL; Kohler C; Lisovicz N
Oncologist; 2015 Jun; 20(6):621-6. PubMed ID: 25926351
[TBL] [Abstract][Full Text] [Related]
20. Survival in Cervical Cancer and Its Predictors at Ocean Road Cancer Institute From January to December 2012.
Khamis SI; Mrema AS; Katanga J; Lugina EL
JCO Glob Oncol; 2021 May; 7():734-739. PubMed ID: 34010012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
